Trials / Conditions / Germline BRCA2 Gene Mutation
Germline BRCA2 Gene Mutation
6 registered clinical trials studyying Germline BRCA2 Gene Mutation — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of Cancer NCT07436312 | Gustave Roussy, Cancer Campus, Grand Paris | N/A |
| Active Not Recruiting | Niraparib + Dostarlimab In BRCA Mutated Breast Cancer NCT04584255 | Dana-Farber Cancer Institute | Phase 2 |
| Unknown | Molecular Profiling in Prostate Cancer NCT04983628 | Hellenic Cooperative Oncology Group | — |
| Recruiting | Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Ca NCT04090567 | M.D. Anderson Cancer Center | Phase 2 |
| Terminated | Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection NCT04668521 | Aspira Women's Health | — |
| Active Not Recruiting | Prospective Study of MAstectomy With Reconstruction Including Robot Endoscopic Surgery NCT04585074 | Severance Hospital | — |